FineMark National Bank & Trust’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
Other funds holding CLOV
GCP
GCM
FineMark National Bank & Trust's CLOV Position: Q4 2021 in Review
FineMark National Bank & Trust sold out of Clover Health Investments (CLOV) in Q4 2021, closing a stake of 27,500 shares — an estimated $203K sold.
FineMark National Bank & Trust first reported a position in CLOV in Q1 2021 and held it in 3 quarters. The position peaked at $567K in Q1 2021. 161 funds tracked by Wall St. Rank hold CLOV as of Q4 2021.
- FineMark National Bank & Trust reported no remaining Clover Health Investments position as of Q4 2021 after selling out during the quarter.
- FineMark National Bank & Trust sold 27,500 Clover Health Investments shares in Q4 2021, an estimated $203K.
- FineMark National Bank & Trust first reported a position in Clover Health Investments in Q1 2021 and held it in 3 quarters.
- FineMark National Bank & Trust's Clover Health Investments position peaked at $567K in Q1 2021.
- 161 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2021.
Based on FineMark National Bank & Trust's 13F filing for Q4 2021, filed 14 Feb 2022.